ADAMs (a disintegrin and metalloprotease) are transmembrane proteins involved in a variety of physiological processes and tumorigenesis. Recently, ADAM8 has been associated with poor prognosis of lung cancer. However, its contribution to tumorigenesis in the context of lung cancer metastasis remains unknown. Native ADAM8 expression levels were lower in lung cancer cell lines. In contrast, we identified and characterized two novel spliced isoforms encoding truncated proteins, D18a and D14 0 , which were present in several tumor cell lines and not in normal cells. Overexpression of D18a protein resulted in enhanced invasive activity in vitro. ADAM8 and its D14 0 isoform expression levels were markedly increased in lung cancer cells, in conditions mimicking tumor microenvironment. Moreover, addition of supernatants from D14 0 -overexpressing cells resulted in a significant increase in tartrate-resistant acid phosphatase þ cells in osteoclast cultures in vitro. These findings were associated with increased pro-osteoclastogenic cytokines interleukin (IL)-8 and IL-6 protein levels. Furthermore, lung cancer cells overexpressing D14 0 increased prometastatic activity with a high tumor burden and increased osteolysis in a murine model of bone metastasis. Thus, the expression of truncated forms of ADAM8 by the lung cancer cells may result in the specific upregulation of their invasive and osteoclastogenic activities in the bone microenvironment. These findings suggest a novel mechanism of tumor-induced osteolysis in metastatic bone colonization.
ADAMs (a disintegrin and metalloprotease) are transmembrane proteins involved in a variety of physiological processes and tumorigenesis. Recently, ADAM8 has been associated with poor prognosis of lung cancer. However, its contribution to tumorigenesis in the context of lung cancer metastasis remains unknown. Native ADAM8 expression levels were lower in lung cancer cell lines. In contrast, we identified and characterized two novel spliced isoforms encoding truncated proteins, D18a and D14 0 , which were present in several tumor cell lines and not in normal cells. Overexpression of D18a protein resulted in enhanced invasive activity in vitro. ADAM8 and its D14 0 isoform expression levels were markedly increased in lung cancer cells, in conditions mimicking tumor microenvironment. Moreover, addition of supernatants from D14 0 -overexpressing cells resulted in a significant increase in tartrate-resistant acid phosphatase þ cells in osteoclast cultures in vitro. These findings were associated with increased pro-osteoclastogenic cytokines interleukin (IL)-8 and IL-6 protein levels. Furthermore, lung cancer cells overexpressing D14 0 increased prometastatic activity with a high tumor burden and increased osteolysis in a murine model of bone metastasis. Thus, the expression of truncated forms of ADAM8 by the lung cancer cells may result in the specific upregulation of their invasive and osteoclastogenic activities in the bone microenvironment.
Introduction
Lung cancer is the leading cause of cancer death throughout the world (Jemal et al., 2002) . The 5-year survival rates for lung cancer are o15% in all developed countries. It is estimated that 30-40% of lung cancer patients with advanced NSCLC suffer from bone metastasis (Coleman, 1997) . Patients with bone metastasis experience pain, metabolic syndromes and spinal cord compression associated with pathological fractures as a consequence of osteolytic lesions.
ADAMs (a disintegrin and metalloprotease) form a large family of cell-surface proteins, which are characterized by disintegrin and metalloproteinase domains, that possess adhesive properties and proteolytic activities, respectively (Lu et al., 2007) . The majority of ADAMs require removal of their prodomain by proprotein convertases to become catalytically active. Other typical domains include the cysteine-rich, epidermal growth factor -like, transmembrane and short cytoplasmic domains (Seals and Courtneidge, 2003) . Over 40 different ADAMs have been identified that have important roles in extracellular matrix remodeling, cell migration and signaling. ADAMs modulate extracellular signals through their sheddase activity by processing several membrane-bound proteins including cytokines, growth factors and their receptors (Seals and Courtneidge, 2003) . In the context of lung cancer, the metalloprotease (MMP) domains of ADAM10 and ADAM17 are key components in the epithelial-derived growth factor receptor signaling cascade that mediate proteolytic shedding of its membrane-tethered ligands (Blobel, 2005 , Sahin et al., 2004 .
Recent studies have focused on ADAM8, which is expressed in the immune and central nervous systems (Hooper and Lendeckel, 2005) . It contains a proline-rich SH3 cytoplasmic tail suggesting that it interacts with other cytoplasmic proteins (Yoshida et al., 1990) . In contrast to several other related molecules, ADAM8 is activated by its autocatalytic activity (Schlomann et al., 2002) . Conditional deletion of ADAM8 shows no apparent phenotype, despite its marked expression in bronchioepithelial cells in the lungs, salivary glands and kidney (Kelly et al., 2005) . ADAM8 has been shown to participate in the allergic inflammatory response (Foley et al., 2007 , King et al., 2004 , Matsuno et al., 2006 . in vitro ADAM8 has been shown to process CD23 (Fourie et al., 2003) , myelin basic protein (Amour et al., 2002) and a peptide derived from interleukin (IL)-1 type II receptor . ADAM8 is upregulated in various tumors including lung and brain tumors , and is considered to be a prognostic marker for renal cell carcinomas and the best predictor of distant metastasis (Roemer et al., 2004a b) . Recently, it has been suggested that the expression of ADAM8 may be an early prognostic marker for lung adenocarcinomas (Ishikawa et al., 2004) . It has also been shown that ADAM8 stimulates osteoclast differentiation (Choi et al., 2001) . Thus, we sought to investigate the involvement of lung tumor-derived ADAM8 in the mechanisms of osteolysis and bone destruction during lung cancer metastasis to bone.
In this study, we have identified several differentially truncated ADAM8 isoforms in human lung tumor cells that confer different invasive properties in vitro. Differential regulation of these isoforms was observed under the conditions that mimicked tumor-stroma interactions. The D14 0 isoform markedly increased the osteoclastogenic activity in an in vitro assay. Furthermore, D14
0 -overexpressing cells induced bone metastasis with increased tumor burden and tumor-induced bone osteolysis in an in vivo model of metastasis. These findings suggest that ADAM8 alternative splicing variants participate and contribute to the deleterious effects of tumor-derived bone metastasis.
Results

Characterization of ADAMs in lung cancer cell lines
In a long-term project searching for alternative splice variants of ADAM proteins altered in lung cancer, we focused in ADAM8, as it has been found elevated in lung cancer patients (Ishikawa et al., 2004) . We carried out a conventional semiquantitative reverse transcriptase-PCR strategy in a battery of human lung tumor cell lines and primary normal human bronchial epithelial (NHBE) cells. Using primers for ADAM8, we found that two isoforms were amplified. The bottom band corresponded to a coamplification of two species: the expected native ADAM8 amplicon and a novel splicing variant, which we called DADAM8-18a (D18a) (Figure 1a) . The other amplified transcript (top band) represented another novel alternatively spliced isoform, named DADAM8-14 0 (D14 0 ). Full-length DADAM8-18a (D18a) and DADAM8-14 0 (D14 0 ) were cloned and sequenced.
To more accurately assess the relative levels of the new isoforms, we used quantitative real-time PCR with specific primers to each isoform. We found that D14 0 isoform was upregulated in small cell lung cancer (SCLC) cell lines as compared with primary NHBE cells. In contrast, D18a was more abundantly expressed in some adenocarcinoma cell lines (Figures 1b) . The exon-intron organization of ADAM8 is shown in Figure 2 (Figure 2b ). The divergent carboxy terminal of D18a showed no similarity to any other proteins in the common databases. In all, five potential N-linked glycosylation sites (NX; S/T) were present, four of which were also found at the same position in native ADAM8, whereas the fifth was located at position 698 within the new carboxy terminal (Figure 2b) .
The other splice variant D14 0 , contained an open reading frame of 1620 nucleotides encoding 539 amino acids (B59 kDa). The D14 0 isoforms encompassed 14 exons and retained intron 14. The retention of intron 14 introduced a novel frameshift with a premature TAA stop codon. The last 56 nucleotides of the D14 0 open reading frame encoded a novel 17 amino-acid sequence with no similarity to any other known protein (Figure 2c ). In all, three out of four N-linked glycosylation sites were similar to the wild-type ADAM8 (Figure 2c ).
Expression of hADAM8 isoforms in cell lysates and culture supernatants
We sought to compare the protein levels of ADAM8 in tumor cell lines and normal NHBE cells. Owing to the complexity of ADAM8 protein processing, immunoblotting analysis was carried out with different antibodies on cell lysates and culture supernatants. The most reliable results were obtained with an antibody recognizing the MMP domain. Several immunoreactive bands were consistently detected for ADAM8: a B90 kDa 'processed form' that was catalytically active, consistent with propeptide removal; and a 'remnant' form with an apparent Mr of B60 kDa (Schlomann et al., 2002) . All these bands represented membranebound forms of ADAM8 (Figure 3a) . The processed form was not observed in SCLC cell lines, whereas it was detected in NHBE and in all NSCLC cell lines tested. In contrast, the remnant form, absent in NHBE cells, was detected in all SCLC and NSCLC cell lines tested (Figure 3b ).
In the conditioned medium, only a B65 kDa isoform that has been previously described (Mandelin et al., 2003) (recognized by the A8h-MD antibody) was detected in the nontransformed epithelial lung cell line (NHBE) (Figure 3c ).
Overexpression and inhibition of ADAM8 isoforms in A549 and H460 cells To examine the roles of different isoforms of ADAM8, we retrovirally transduced A549 and H460 cell lines with constructs encoding native ADAM8 (wild-type A8) and its DADAM8-18a (D18a) and DADAM8-14 0 (D14 0 ) isoforms. Higher levels of 75-kDa protein were detected in wild-type A8-transfected cells as compared with mock-transduced cells using western blot analysis with the MD (metalloprotease domain) antibody (Figure 4a ).
In D18a-transduced cells a B70-kDa isoform was detected together with overexpression of the 75-kDa isoform. In both H460 and A549 cells transduced with D14 0 , a B68-kDa band was detected with a slight increase in the expected molecular weight presumably due to glycosylations. No changes were observed in the conditioned media of transduced cells (data not shown).
For knockdown experiments, we stably transfected A549 and H460 cells with the ADAM8 vector containing two different small interfering RNA (siRNA) constructs or a scrambled nonspecific siRNA sequence. Western blot analysis revealed robust inhibition of the 75 kDa processed isoform in cell lysates (Figure 4b ). Densitometric analysis of the reactive bands revealed a decrease between 80 and 90% for A549 cells, and 70 and 80% for H460 cells. Interestingly, inhibition of ADAM8 in both cell lines led to a concomitant increase in the D14 0 isoform, which was stronger in A549 cells as compared with H460 cell line, whereas D18a expression levels in knockdown transfectants were cell-line dependent. (Figure 4c ). Although both siRNA targets (1 in exon 17 and the other in exon 19) could theoretically inhibit native ADAM8 and D18a isoforms, but not the D14 0 isoform, it appears consistent that the upregulation of D14 0 isoform results as a compensatory mechanism in response to decreased native ADAM8.
The invasive activity of the ADAM8 isoforms We studied the invasive properties of different ADAM8 isoforms in vitro in two different cell lines H460 and A549 in a Boyden chamber assay. As a chemoattractant, we used conditioned medium derived form murine ST-2 stromal cells. A marked increase in the invasive activity of H460 and A549 cells was detected in cells, overexpressing native ADAM8 and its D18a isoform (Po0.001), as compared with the mock-transduced and parental cells (Figure 5a ). In contrast, the invasive ability of D14 0 -transduced cells was significant (Po0.05), whereas in A549, D14 0 -transduced cells showed a dramatic increased invasive activity (Po0.0001). Knockdown of ADAM8 using two different siRNA in both cell lines showed a significant decrease in invasiveness as compared with control cells (Figure 5b ). These results suggest that ADAM8, and both D18a and D14 0 isoforms contribute to increase invasiveness in lung cancer cells. NHBE  H69  H82  H209  H510  N417  H23  HCC44  SKLU1  PC14  HCC827  H358  A549  H322  HCC15  CALU-1  LUDLU-1  H1703  H157  SK-MES1  H1299  H460  H661  H720 
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Regulation of ADAM8 and its isoforms by tumor-stroma interactions Tumor-stroma interactions have been shown to be critical for tumor initiation, progression and metastatic development (Hanahan and Weinberg, 2000) . Thus, to determine the role of cell-cell interactions in the regulation of ADAM8, human H460 and A549 cells were cocultured with murine stromal ST-2 cells to mimic the tumor-stroma microenvironment. Under these conditions, D14 0 expression levels were markedly upregulated in H460 cells and slightly increased in A549 cells, whereas D18 levels remained unchanged Mechanism of bone colonization I Hernández et al (data not shown). These findings suggest that the effects of D14 0 might be exacerbated in conditions that promote tumor-stroma interactions (Figure 5c ).
Effects of ADAM8 and its isoforms on osteoclastogenesis
A soluble isoform of murine ADAM8 has been previously implicated in osteoclastogenesis (Choi et al., 2001) . To examine the role of ADAM8 isoforms in osteoclastogenesis, conditioned media from cells overexpressing native ADAM8, D18a or D14 0 isoforms, were added to mouse bone marrow macrophages to study their ability to induce osteoclast formation. In the presence of macrophage colon-stimulating factor and receptor-activated nuclear factor-k B-ligand, the conditioned media from D14 0 -expressing cells led to a significant increase in osteoclast differentiation for both H460 (Po0.001) and A549 (Po0.01) cells (Figure 6a ). The conditioned media from native ADAM8 and its D18a isoform were not significantly different from the media of mock-transduced cells.
Although native ADAM8 was expressed in low levels in several lung cancer cell lines, whereas several splicing isoforms were upregulated in tumor cells as compared with normal NHBE cells, we sought to determine the consequences of ADAM8 inhibition. Interestingly, conditioned media from native ADAM8 siRNA-inhibited A549 and H460 cells led to a slight increase in the Figure 4 Overexpression and knockdown of ADAM8 isoforms. (a) Wild-type ADAM8 and its D18a and D14 0 isoforms were cloned into pBabe-Neo and transduced into H460 and A549 lung tumor cell lines. ADAM8 isoforms were detected by western blot analysis using the A8h-MD antibody. Full-length ADAM8 (%), D18a (v) and D14 0 ($) are shown in lysates. (b) Several targets against ADAM8 were designed as siRNA and transfected into H460 and A549 cells. A nonspecific siRNA sequence (scramble) was used as the negative control. ADAM8 expression was analyzed by western blot analysis using the A8h-MD antibody. (c) Expression levels of D18a and D14 0 after knockdown of full-length ADAM8 were assessed by semiquantitative reverse transcriptase-PCR. Numbers denote the densitometric analysis carried out using AnalySIS image analysis system. 
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1.44 1 Figure 5 Invasion and coculture experiments. (a) Invasion assays using H460 and A549 cells overexpressing wild-type ADAM8, D18a and D14 0 isoforms, and wild-type ADAM8 knockdown transfected cells were carried out in a Boyden chamber stimulated with conditioned medium of ST-2 cells. In both cell lines, overexpression of full-length ADAM8 and D18a increased invasion dramatically, whereas such effect was milder in D14 0 transduced cells. (b) Invasion was decreased in ADAM8 knockdown cells in H460 and A549 cell lines under these experimental conditions. (c) H460 and A549 cells were incubated with medium alone or in the presence of the murine marrow stromal cell line ST-2 for 3 days after confluency. Specific semiquantitative reverse transcriptase-PCR was used to assess human gene expression of the different isoforms. The D14 0 isoform was upregulated by cell-cell interactions in both cell lines. Experiments were repeated three times with identical results. Numbers denote densitometric quantification of the bands (*Po0.05, **Po0.01,***Po0.001).
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I Hernández et al number of multinucleated tartrate-resistant acid phosphatase (TRAP) þ cells (Figure 6a ). To determine whether this effect was mediated by proosteoclastogenic factors secreted in the conditioned media, we used enzyme-linked immunosorbent assay to measure the levels of several factors previously implicated in osteoclastogenesis, including receptor-activated nuclear factor-k B-ligand, such as interleukin (IL)-6, tumor necrosis factor-a, IL-8 (De Larco et al., 2001 ) and MIP-1a (Mundy, 2002) . Interestingly, the pro-osteoclastogenic cytokine IL-8 was upregulated in the conditioned media from H460 and A549 cells overexpressing D14 0 . Furthermore, ADAM8 siRNA in both cell lines resulted in an increase in D14 0 expression together with an almost twofold increase in IL-8 protein secretion levels as compared with scramble siRNAtreated cells (Figure 6c ). In contrast, only D14 0 -overexpressing H460 cells secreted high IL-6 levels, whereas IL-6 levels in A549 overexpressors were undetected. These differences were probably related to the different histological origin of these tumor cell lines. No differences in IL-11, osteoprotegerin, receptor-activated nuclear factor-k Bligand and MIP-1a levels were observed (data not shown). These results indicate that the presence of D14 0 isoform leads to an increase in the pro-osteoclastogenic cytokine secretion, which may partially contribute to the enhanced osteoclast formation in vitro.
To assess whether the increase in osteoclast differentiation was mediated by IL-8 and/or IL-6, we treated the conditioned media derived from D14 0 -overexpressing A549 and H460 cells with IL-8 and IL-6 blocking antibodies or their combination. The conditioned media was subsequently used to perform an in vitro osteoclastogenic assay. No differences were obtained in the area or the number of TRAP þ cells (data not shown). These data suggest that IL-8 and/or IL-6 are not sufficient to mediate the pro-osteoclastogenic effects observed in D14 0 -overexpressing cells.
The effects of ADAM8 and its isoforms in vivo Previous in vitro studies have suggested that ADAM8 could have a role in the acquisition of an aggressive phenotype (Ishikawa et al., 2004 , Valkovskaya et al., 2007 . Thus, we examined the extent to which the D14 0 isoform mediated these detrimental effects. To this aim, we selected human adenocarcinoma A549 cells, which represent the most frequent histological subtype in NSCLC. By inoculation of lung cancer cells in athymic nude mice, this model induces rapid and reproducible metastasis to long bones (data not shown).
When we inoculated ADAM8-overexpressing A549 cells into athymic nude mice, bone lesions were evident 
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by X-ray 20 days after inoculation. No differences were found in the number and area of the osteolytic lesions of ADAM8-inoculated mice as compared with mock-transduced inoculated animals (data not shown). However, the overall survival curve revealed a higher mortality in animals inoculated with ADAM8 compared with control cells (data not shown). The cause of lethality could not be determined from necropsy of the animals. However, cachexia developed faster in ADAM8-inoculated animals than in control mice. These findings suggest that an unknown direct or indirect effect mediated by ADAM8 may be critically affecting survival.
In contrast, when we inoculated D14 0 -overexpressing cells we found slight but significant decrease in the time of appearance of bone metastatic lesions in this animals as compared with control mice (Po0.05) (Figure 7a ). These results were correlated with a significant increase in the area of osteolytic lesions over time, as assessed by X-ray image analysis and m-computerized tomography scan (Figures 7b and c) compared with mock-transduced inoculated animals. Histological analysis of long bones derived from D14 0 animals revealed a complete colonization of the bone marrow compartment with destruction of cortical bone in the metaphyseal region.
In contrast, discrete focal colonies of tumoral cells were found in long bones of control mice at 34 days after inoculation. To investigate whether these lesions were caused by an increase in bone resorption, TRAP staining was carried out to reveal the presence of osteoclasts. At the interface between the periosteum and the cortical bone, and consistent with previous findings, the number of multinucleated TRAP þ osteoclasts per bone interface was significantly increased in D14 0 -inoculated animals (Po0.01) (Figure 7d ). These data suggest that both ADAM8 and its D14 0 isoform contribute to an aggressive tumor phenotype in vivo. Moreover, D14 0 isoform expression results in the faster development of aggressive osteolytic lesions, mediated by an increase in osteoclast number and higher invasive activity.
Discussion
We have identified several novel truncated isoforms of ADAM8 derived from alternative splicing in lung cancer cells and shown that their functional involvement in Mechanism of bone colonization I Hernández et al invasiveness and osteoclastogenesis contributes to their aggressive phenotype. In a bone metastasis model of NSCLC in vivo, these isoforms cooperate to increase osteolytic metastasis during the early stages of colonization leading to an increased osteolytic area of metastasis. Our findings unveil a novel mechanism by which tumor cells are able to thrive in the bone compartment. The identification of previously undescribed ADAM8 isoforms represents a common feature of the ADAMs family. Previously, two phylogenetically related members, ADAM12 and ADAM28, that share an identical exonic structure with ADAM8, have been shown to generate truncated variants with a high degree of structural similarity (Gilpin et al., 1998 , Haidl et al., 2002 . Both the D18 isoform of ADAM8 and the s12-splicing variant of ADAM12 contain a frameshift insertion, generated by the partial intronic transcription that yields a truncated protein, which lacks a transmembrane domain. Similarly, the ADAM28s isoform contains a novel translated sequence of 56 nucleotides in intron 14 that results in a truncated protein with a 17 amino acid short cysteine-rich domain, remarkably similar to the D14 0 isoform. These findings suggest a similar evolutionary origin (Fourie et al., 2003) (Kim et al., 2006) and highly conserved mechanism of splicing among different ADAM family members.
More importantly, ADAM8 truncated isoforms also showed distinct functions compared with the native protein, as previously reported for other members of the ADAMs family (Reiss et al., 2006, Seals and Courtneidge, 2003) . In agreement with these earlier studies, the novel D14 0 isoform identified in this report showed a marked increase in the induction of TRAP þ cells. Previous studies have described a 65 kDa human soluble isoform and a 70 kDa truncated murine isoform of ADAM8, structurally similar to the D14 0 isoform (Choi et al., 2001 , Mandelin et al., 2003 . This soluble murine ADAM8 isoform induced the formation of boneresorbing osteoclasts and acted at later stages of osteoclast differentiation and precursor fusion (Choi et al., 2001) . The fact that this murine form was structurally and functionally related to the D14 0 isoform, which also exhibited a similar pro-osteoclastogenic effect, emphasizes the relevance of ADAM8 in osteoclastogenesis (Choi et al., 2001 , Mandelin et al., 2003 , Rao et al., 2006 , Verrier et al., 2004 . This effect on osteoclast formation was mediated by the interactions between the disintegrin domain and a9b1 integrin (Rao et al., 2006) . Indeed, D14 0 isoform lacks the hypervariable region, so the intact disintegrin domain would be more readily available to interact with an integrin molecule. In contrast, three-dimensional data suggest that the disintegrin domain in wild-type ADAM8 would be partially hidden by the hypervariable region (Takeda et al., 2007) . These structural differences could explain the higher activity of the D14 0 isoform than the full-length isoform in the fusion of mononuclear precursors. Another critical domain for osteoclast formation, the cysteine-rich domain, would be partially preserved in the D14 0 isoform. However, an earlier study showing that a truncated isoform of ADAM8 lacking the MMP domain had a similar effect to the D14 0 isoform, suggests that the MMP domain would be dispensable for the activity of D14 0 (Choi et al., 2001) . Of note, the novel juxtaposed 14 amino-acid sequence remarkably contains several cysteines, which could preserve its functional activity.
Our data suggest that D14 0 activity could be mediated by the shedding or activation of secondary targets that participate in osteoclastogenesis. Several findings support this contention. First, D14 0 upregulation in conditions that mimic tumor-stroma interactions supports its role in the cell-cell interactions. Second, the fact that both forms were detected in cell lysates rather than in conditioned media supports a putative role as a sheddase or in integrin binding. Finally, we found that a pro-osteoclastogenic cytokines IL-8 and IL-6 were upregulated in cells overexpressing the D14 0 isoform. Interestingly, production of IL-8 was driven by ADAMb1 integrin interactions in natural killer cells (Mainiero et al., 2000) . On the basis of these findings, it is tempting to speculate that the binding of the D14 0 isoform to b1-integrin in tumor cells may activate downstream signaling events that lead to the subsequent release of IL-8 and osteoclast formation. A similar mechanism for IL-6 upregulation has been described in osteoblasts after interactions between the ADAM9 disintegrin domain and a v b 5 (Karadag et al., 2006) . Although both IL-6 and IL-8 were elevated, their blockade was not sufficient to decrease osteoclast differentiation in vitro, suggesting that other unidentified pro-osteoclastogenic factors released in the conditioned media of D14 0 -overexpressing cells might account for this effect.
Besides the integrin-ADAM interaction, the specific targets of the metalloproteinase domains remain elusive. in vitro studies have shown that ADAM8 can process several molecules including CD40, tumor necrosis factor-a, IL1R and the immunoglobulin E receptor CD23 (Fourie et al., 2003) . Only the CHL1 neural-cell adhesion homolog (Naus et al., 2004) , NCAM-140 (Hinkle et al., 2006) and L-selectin (Gomez-Gaviro et al., 2007) have been shown to be processed by ADAM8 in vivo. Whether these or other unknown adhesion molecules can be targeted by ADAM8 during invasion remains to be addressed. Our findings support an unambiguous role of full-length ADAM8 in the invasiveness of H460 and A549 cells, in agreement with previous findings (Ishikawa et al., 2004 , Valkovskaya et al., 2007 . Although D18a contributed to the increased invasiveness observed here, its role still remains unclear, especially as forced expression was associated with concomitant overexpression of the native protein. The proinvasive activity induced by wild-type ADAM8 would require the coordinated activity of cell-matrix adhesion and degradation, cytoskeleton organization and motility. Previous findings have suggested a role for ADAM12, which is closely related to ADAM8, in the extracellular processing of target substrates that favor motility and cytoskeletal remodeling (Kveiborg et al., 2008) such as Src (Stautz et al., 2010) , through interactions with key components of cell-matrix adhesion such as actinin-1 (Cao et al., 2001 ) and actinin-2 (Galliano et al., 2000) . Similarly, ADAM8 has been implicated in the processing of adhesion proteins in other systems (Hooper and Lendeckel, 2005) . Both membrane-anchored and secreted forms of ADAM8 would participate in matrix adhesion (Schlomann et al., 2002) , whereas other MMPs could process the adhesive proteins resulting in migration (Gomez-Gaviro et al., 2007) . A related mechanism has been suggested for the processing of vascular cell adhesion molecule on eosinophils (Garton et al., 2003 , Matsuno et al., 2007 and L-selectin on neutrophils (Gomez-Gaviro et al., 2007) . Interestingly, ADAM8 was found in intracellular vesicles (Gomez-Gaviro et al., 2007 , Verrier et al., 2004 , a location associated with the cargo transport of MMP and other molecules to the extracellular microenvironment, which would allow cell invasion.
These in vitro findings were associated with the early development in osteolytic lesions in the process of bone metastasis. We have recently shown in a model of NSCLC bone metastasis that tumor development in the bone compartment is mediated by two distinct mechanisms (Vicent et al., 2008) . During the early stages, bone osteolysis is driven by tumor-induced osteoclastogenesis. In the later stages, tumor-stroma interactions might be more significant in increasing metalloproteolytic activity resulting in bone destruction and metastatic growth, probably due to increased invasiveness and osteoclastogenesis. In this scenario, ADAM8-derived isoforms would contribute to the early stages of metastatic development in vivo. Interestingly, overexpression of ADAM8 protein was significantly more common in tumors from the patients with locally advanced lung cancer or distant organ metastases than those with earlier stage disease (Ishikawa et al., 2004) . On the basis of their close similarity to ADAM8 as well as their redundant roles shown in the other systems, other ADAMs may functionally cooperate with ADAM8. In this regard, the closely related isoform ADAM28s is overexpressed in the human NSCLCs and its high expression levels are correlated with lymph node metastasis (Ohtsuka et al., 2006) . More importantly, several ADAMs have been shown to mediate epithelialderived growth factor receptor transactivation induced by G-protein-coupled receptors in various cells or tissues. ADAM10, ADAM12, ADAM15 and ADAM17 were able to shed epithelial-derived growth factor receptor ligands including heparin binding epidermal growth factor, transforming growth factor-a and amphiregulin after cell stimulation with G-proteincoupled receptor agonists such as angiotensin II, lipopolysaccharide, IL-8, lipoteichioc acid, phenylephrine, carbachol or bombesin, leading to activation of epithelial-derived growth factor receptor-mediated signaling pathways (Blobel, 2005 , Gee and Knowlden, 2003 , Higashiyama and Nanba, 2005 , Ohtsu et al., 2006 . These data emphasize the fact that global inhibition of ADAMs may be highly beneficial in the development of antimetastatic therapies. Indeed, a broad MMP/ADAM inhibitor GM6001 was found to be effective in inhibiting bone metastasis progression in a NSCLC animal model (Vicent et al., 2008 ).
In conclusion, we have identified novel truncated forms of ADAM8 that were upregulated in tumor cells. Characterization of their functional role in vitro revealed increased invasive abilities and osteoclastogenic properties, and correlated with the early development of metastatic lesions in vivo (Figure 8 ). In this context, these truncated isoforms that were upregulated by tumor-stroma interactions could induce a high tumor burden and tumor-induced osteolytic lesions, by a mechanism that may involve IL-6 and IL-8. These findings suggest a novel mechanism of bone colonization in lung cancer bone metastasis. ADAM8 and its spliced variants would allow tumor cells to thrive in the bone compartment by a triple action. As a consequence of perturbed splicing machinery, (1) the D14 0 isoform would bind to integrins including a 9 b 1 , thereby initiating a signaling cascade that leads to increased secretion of pro-osteoclastogenic cytokines IL-8 and IL-6. Complementary, ADAM8 and its isoforms could associate with MMPs in cargo vesicles modulating their extracellular transport and activity (2). Cytokine release into the extracellular milieu or direct shedding by ADAM8 MMP processing would then contribute to increase osteoclastogenesis and invasion (3). This increase induced by the D14 0 isoform would be modulated by complex tumor-stroma interactions and bone matrix-derived factors that would exacerbate invasiveness, osteoclastic activity leading to deleterious osseous lesions.
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I Hernández et al bronchioalveolar primary cells were also used: NHBE (Clonetics, Lonza, Cologne, Germany) was grown in BECGM Systems (Cambrex, Karlskoga, Sweden). ST-2 murine stromal cells were grown using Dulbecco's modified Eagle's medium with ultraglutamine (Cambrex).
ADAM8 antibodies
A8-MD is a polyclonal rabbit antibody against a peptide partially, overlapping the catalytic and disintegrin domains of human ADAM8 (ab11527, Abcam, Cambridge, UK). a-b-Actin was a monoclonal anti-b-actin (clone AC-15, Sigma, St Louis, MO, USA).
Cloning of human ADAM8 and isoforms
The primer sequences used for the screening were as follows: 5 0 -ATGTGTGACCTCGAGGAGTTCT-3 0 and 5 0 -GGATGT CATAGGAGAAGCAGGA-3 0 . Primer sequences used for real-time PCR were as follows: 5 0 -GGACCAGAAGCGGGT TAG-3 0 and 5 0 -AGGTGAAGTGGGCACAGAG-3 0 for D14 0 and primers 5 0 -TGACTGAGGTGCACGCAGCCC-3 0 and 5 0 -GGCTCCCGGACGCTTACACTG-3 0 for D18a. The primer sequences used for cloning were as follows: 5 0 -GCAGGAACC AGACCGTGT-3 0 (5 0 untranslated region sequence) and 5 0 -GA TGCATTACTGAGGTTAGAACAGC-3 0 (3 0 untranslated region sequence) for full ADAM8 (fragment of 2680 bp expected); Previous 5 0 untranslated region sequence and 5 0 -TGTGGGACC AGAAGCGGGTTA-3 0 (intron 14 sequence) for truncated ADAM8 (fragment of 1689 bp expected). The PCR conditions were 94 1C for 5 min; 94 1C for 30 s, 60 1C for 45 s, 68 1C for 3 min for 40 cycles and a final extension at 68 1C for 10 min. Selected fragments were extracted with Gel Extraction Kit (Qiagen, Hilden, Germany) cloned in the pCR Blunt II TOPO (Invitrogen) and sequenced to verify insert fidelity and integrity.
Transfections and knockdown
Insert complementary DNAs for wild-type ADAM8 , D18a and D14 0 were excised and subcloned in retroviral vector, pBabe-Neo (Addgene, Cambridge, MA, USA), After infection of the cell lines H460 and A549, antibiotic-resistant pools were expanded and frozen at first passages. Cells were screened by western blotting to assess expression levels after transduction. For knockdown experiments, short hairpin RNAi constructs were cloned into pSilencer 4.1-CMV neo (Ambion, Austin, TX, USA). Transfection was carried out with Lipofectamine 2000 (Invitrogen) method in both cell lines. The pSilencer 4.1-CMV neo with a scramble sequence was used as mock. Geneticin-resistant clones that stably express the short hairpin RNAis were expanded and frozen at first passages. The sequences that resulted in an effective knockdown were as follows: ADAM8-1999: 5 0 -AGGACGTTGCCAGGACTT ACA-3 0 (siRNA1); ADAM8-2221: 5 0 -AGGCATCATCGTCT ACCGCAA-3 (siRNA2).
Coculture conditions
A total of 500 000 ST2 cells were seeded with or without 1 Â 10 6 H460 or A549 cells and grown for 3 days. Conditioned media obtained after 24 h incubation with serum-free medium under these coculture conditions was collected together with lysates for subsequent protein and RNA extraction. Other methods are included as supplementary information.
In vivo assays All protocols were approved by the local Committee on Animal Research and Ethics. Female athymic nude mice, 3 weeks old (eight animals per group), were inoculated with different cells. Mice were killed 28 days after inoculation as previously described (Gonzalez et al., 2007) .
Invasion assays
Invasion assays were carried out with conditioned medium from murine bone marrow stromal ST-2 cells as chemoattractant placed in the lower compartment of 8-mm pore Boyden chamber. Cells (2 Â 10 5 ) were seeded in each well, in sixplicate for each condition. The upper chamber was precoated with 420 ng matrigel per ml (Sigma) dried at room temperature for 5 h. Cells (5 Â 10 4 ) were seeded on the upper compartment in serum-free medium per well in 24-well plates (Corning Life Sciences, Chorges, France). After 24 h, cells on the top chamber were wiped with a cotton swab, and cells in the lower compartment were fixed and stained with crystal violet. Number of invasive cells was evaluated with a computerized image analysis system, AnalySIS (Mu¨nster, Germany).
Statistical analysis
To study differences in invasion activity and osteoclastogenic activity, data were analyzed by one-way analysis of variance, and Bonferroni post hoc test. SPSS software (Chicago, IL, USA) was used for the analysis. Values were expressed as means ± s.d. and statistical significance was defined as Po0.05 (*), Po0.01 (**), Po0.001 (***). To analyze the results of in vivo assays, the one-tailed Mann-Whitney U-test for nonparametric samples was used.
Abbreviations MMP, metalloprotease; NSCLC, nonsmall cell lung cancer; SCLC, small cell lung cancer; TRAP, tartrate-resistant acid phosphatase.
